Determinants of human tumor sensitivity to fluorinated pyrimidine chemotherapy.
D004273:DNA, Neoplasm / Q000378:metabolism; D005467:Floxuridine / Q000378:metabolism*; D005472:Fluorouracil / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D008025:Ligases / Q000378:metabolism; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D010770:Phosphotransferases / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D013937:Thymidine Kinase / Q000378:metabolism; D014500:Uracil Nucleotides / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D004273:DNA, Neoplasm; D014500:Uracil Nucleotides; D005467:Floxuridine; D010770:Phosphotransferases; D013937:Thymidine Kinase; D008025:Ligases; D005472:Fluorouracil; D013936:Thymidine; D014529:Uridine